ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (ASMB)

Q: What does CUSIP 045396207 represent in this 13F holders report?

CUSIP 045396207 is the security identifier for ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") used to aggregate holder disclosures.

Q: How many institutions held ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") in Q2 2026?

5 institutional investors reported ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 045396207

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.001 per shares (the "Shares")
Total 13F shares: 214,408
Total 13F value: $5,891,932
Share change: +214,353
SEC-reported price per share: $27.48
Number of holders: 5
Value change: +$5,890,421
Number of buys: 4
Shares outstanding: 15,738,333

Security key

045396207

Report period

Q2 2026

Institutions

Top holders

ASMB full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 ASSEMBLY BIOSCIENCES, INC. SEC filings ASSEMBLY BIOSCIENCES, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 045396207

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026

Ownership snapshot

Top reported holders of ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

GILEAD SCIENCES, INC.

Disclosed value leader

GILEAD SCIENCES, INC.

Comparable rows

15/15

Latest evidence

26 May 2026

3/4/5 13D/G 13F Lead comparable stake: 25% 13D/G row: GILEAD SCIENCES, INC. Showing 1-6 of 15 holder rows.

Quick read

GILEAD SCIENCES, INC. leads the comparable SEC ownership view at 25%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GILEAD SCIENCES, INC.'s linked filing trail.

Comparable ownership Top 5

GILEAD SCIENCES, INC. 25%

Commodore Capital LP 9.9%

RA CAPITAL MANAGEMENT, L.P. 9.5%

Janus Henderson Group Ltd. 8.2%

Farallon Capital Partners, L.P. 7.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
GILEAD SCIENCES, INC.	3/4/5 13D/G 13F 10%+ Owner · Company 3/4/5 13D/G 13F	25% from 13D/G	$138,114,219 7,273,009 shares mixed-class rows	—	26 May 2026
Commodore Capital LP	13D/G 13F Company 13D/G 13F	9.9%	$29,281,576 1,615,981 shares	$0	08 Aug 2025
RA CAPITAL MANAGEMENT, L.P.	13D/G 13F Company 13D/G 13F	9.5%	$28,392,908 1,530,615 shares	$0	11 Aug 2025
Janus Henderson Group Ltd.	13D/G 13F JANUS HENDERSON GROUP PLC · Company 13D/G 13F	8.2%	$44,444,160 1,341,508 shares	$0	28 Nov 2025
Farallon Capital Partners, L.P.	13D/G Dapice Joshua J. 13D/G	7.8%	$38,963,707 1,227,590 shares	+$2,763,919	31 Dec 2025
Paradigm Biocapital Advisors LP	13F 13D/G Company 13F 13D/G	5.4% from 13D/G	$18,460,715 665,251 shares	—	31 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

214,408

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2026 holders

Holder diff

-69

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend